Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Active
RFA-DK-27-108Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract outlines the continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Consortium under the NIH, focusing on advancing research into cardiovascular disease (CVD) in individuals with type 1 diabetes (T1D). Cardiovascular complications remain the leading cause of death among people with T1D, and despite management of traditional risk factors such as blood glucose, blood pressure, and cholesterol, significant residual cardiovascular risk persists. The contract emphasizes the need to better understand the mechanisms behind atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy specific to T1D, as well as the fact that no targeted therapies currently exist to prevent or treat these cardiovascular complications. This solicitation, issued by the National Institutes of Health as part of the Special Diabetes Program, supports collaborative and interdisciplinary research efforts to deepen the understanding of CVD development unique to T1D by continuing the work of the CaRe-T1D consortium. The award mechanism is a U01 cooperative agreement for research without clinical trials, encouraging innovative research collaborations that aim to reduce morbidity and mortality associated with cardiovascular issues in T1D. The application deadline is March 10, 2027, and interested parties can direct inquiries to the NIH contact provided.

General Info

NIH contract continues CaRe-T1D research on cardiovascular disease mechanisms in type 1 diabetes.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(1)

RFA-DK-27-108 CARE-T1D Consortium U01 NOFO

HTML32 pagesrfp

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
Office AddressUSA
Contacts
National Institutes of Health

Full Description

Show more
The NIH Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) was created to improve research on type 1 diabetes (T1D) and cardiovascular disease (CVD). Cardiovascular complications remain the top cause of death among people with T1D and greatly shorten lifespan. The mechanisms underlying atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy in T1D remain poorly understood. While managing traditional risk factors—such as high blood glucose, high blood pressure, and elevated cholesterol lower cardiovascular risk, a significant residual risk remains even with optimal control. In addition to atherosclerosis, both diastolic and systolic diabetic cardiomyopathy play a major role in morbidity and mortality among these patients. Currently, no therapies are specifically approved to prevent or treat these common and severe cardiovascular issues in T1D. The purpose of this NOFO is to promote collaborative and interdisciplinary research aimed at enhancing the understanding of the development of CVD in individuals with T1D and the differences with CVD in T1D by continuing the efforts of the CaRe-T1D consortium.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
ManTech special Broad Agency Announcement (sBAA): Accelerating Maritime Modernization: Innovation in Naval Manufacturing, Sustainment, and Industrial Base Capability
Solicitation # N0001426SB002
The Navy Manufacturing Technology Program is seeking innovative research and development proposals through solicitation N0001426SB002 to enhance shipbuilding and maintenance capabilities by improving speed, throughput, and industrial base resilience. The focus is on transforming shipyards, maintenance depots, and supply chain operations through breakthrough manufacturing technologies that enable faster construction, arming, and repair of naval vessels. Proposals must clearly demonstrate how they remove existing bottlenecks and strengthen the nation’s shipbuilding enterprise by increasing efficiency, adaptability, and competitiveness across the defense industrial base. This initiative is critical to sustaining and modernizing the U.S. naval industrial infrastructure to meet current and future operational demands. Proposals are due by September 16, 2026, and are open to organizations responding to the Small Business Administration Assistance program under NAICS code 541715. The solicitation is managed by the Office of Naval Research in Arlington, Virginia, with primary point of contact Stephanie L. Marsh and secondary contact Miranda Fleck for inquiries. Performance locations are not specified, allowing flexibility for applicants to propose solutions that can be implemented across various U.S. naval manufacturing and maintenance facilities. Interested parties must submit their responses via the SAM.gov portal before the deadline to be considered for funding and collaboration opportunities aimed at revolutionizing naval manufacturing.
Office Of Naval Research

POSTED

1 day ago

DEADLINE

in 19 days
View Details
NAICS: 541715
New
Federal
ARMY OPEN SOLICITATION (AOS)
Solicitation # W9128Z-25-S-A002
The Army Open Solicitation (AOS), identified by solicitation number W9128Z-25-S-A002, is an indefinite, open solicitation issued by the U.S. Army Contracting Command – Aberdeen Proving Ground to rapidly acquire innovative commercial technologies and research-driven solutions across all Army mission areas. Designed to revitalizing the industrial base and enhancing Warfighter lethality, the solicitation leverages a flexible acquisition framework under multiple FAR, DFARS, and U.S. Code authorities, including Other Transactions, Commercial Solutions Opening, and prototype authorities. It supports both Active Capability Gap submissions and periodic Calls for Solutions, with responses evaluated based on technical merit, feasibility, schedule, price estimation, viability, and desirability using a trade-off approach rather than lowest price technically acceptable. The solicitation remains open indefinitely until canceled, with recent amendments through March 2026 expanding and clarifying Army Example Areas, refining submission procedures, and updating contracting information including Active Capability Gap mailboxes. All submissions must adhere to strict formatting requirements, including a single PDF submission not exceeding five pages or fifteen slides, with mandatory inclusion of an executive summary, company information, and rough order of magnitude cost and schedule estimates. Offerors must be registered in SAM, use WAWF for invoicing, and comply with stringent data storage and security requirements, including U.S.-only data hosting and full organizational conflict of interest disclosures. The solicitation encourages participation from small businesses, nontraditional defense contractors, and nonprofit research institutions, with specific certifications required through the Affirmation of Business Status Certification. Performance may occur at government facilities including Aberdeen Proving Ground and other CONUS/OCONUS locations as directed, with award timing anticipated in fiscal year 2026, and support expected through 2032. No fixed contract value is provided, as pricing is determined through competitive evaluation of commercial proposals under the solicitation's open-ended structure.
W6QK Acc-Apg Contr Ctr

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Chemistry Research for the Division of Translational Toxicology (DTT)
Solicitation # 75N94026R00002
The National Institute of Environmental Health Sciences (NIEHS), through its Division of Translational Toxicology (DTT), is seeking chemistry research support to advance the National Toxicology Program’s mission of understanding how environmental factors impact human health. This acquisition, identified by solicitation number 75N94026R00002, is a market research effort aimed at identifying qualified vendors capable of providing comprehensive chemistry services across eight functional areas: Logistics and Handling, Characterization, Formulation, Biosample Analysis, Special Studies, Animal Studies, Omics, and In Vitro Assays. The contractor will be responsible for end-to-end chemistry support, including handling hazardous materials, developing and validating analytical methods, conducting toxicokinetic and ADME studies, and ensuring compliance with FDA Good Laboratory Practices, DOT regulations for chemical transport, and NCI guidelines. Work is to be performed at the contractor’s facilities, coordinated closely with DTT in Bethesda, Maryland, where all data and reports must be submitted electronically through the DTT Program Management System in accordance with Section 508 accessibility standards. The anticipated contract structure includes a ten-year base period with an optional six-month extension, and the government expects to use a Cost Plus Fixed-Fee contract type. Evaluation of future proposals will prioritize technical performance, with Logistics and Handling carrying the highest weight at 30%, followed by key areas such as Biosample Method Development and Chemical Identity and Purity at a weight of five. Proposals must include detailed Quality Management Plans, Health and Safety Plans, and IT Security Plans, all of which must be approved prior to work commencement. Key personnel, including the Principal Investigator and Quality Assurance Officer, must be direct employees of the prime contractor, and subcontractors may not fulfill these roles. Facilities involved in animal work must hold AAALAC accreditation and maintain an active IACUC, while the prime contractor must hold DEA licensing for controlled substances. The solicitation requires respondents to submit a single 15-page Capability Statement via email by March 4, 2026, with the document limited to Word or PDF formats. While this posting is for market research and not a formal solicitation, it sets the stage for a future contract with no set-aside classification under NAICS code 541715, and the government will consider all business sizes in the selection process. Financial and administrative details, including payment methods and accounting codes, will be finalized in the subsequent Request for Proposal.
National Institutes Of Health Nichd

POSTED

1 day ago

DEADLINE

in 19 days
View Details